Related Experiment Videos
[Severe Raynaud's phenomenon associated with interferon-beta therapy for multiple sclerosis: case report]
B A Cruz1, E D Queiroz, S V Nunes
1Faculdade de Medicina, Universidade Federal de Minas Gerais. borisc@net.cm.com.br
Arquivos De Neuro-Psiquiatria
|August 2, 2000
Summary
Interferon-beta (IFN-beta) treatment for multiple sclerosis (MS) may cause severe vascular issues. A patient experienced Raynaud
Area of Science:
- Neurology
- Vascular Medicine
Background:
- Interferon-beta (IFN-beta) is a common treatment for multiple sclerosis (MS).
- Vascular complications are potential adverse effects of IFN-beta therapy.